MONTEREY, Calif. — There is more than one way to treat neurotrophic keratopathy.
In a debate on the topic at the Women in Ophthalmology Summer Symposium, Fasika Woreta, MD, MPH, argued for Dompé’s Oxervate (cenegermin-bkbj) as the preferred treatment, while Michelle Latting, MD, argued for neurotization.
“There are numerous studies showing the effectiveness of the medication,” Woreta said, citing, for one, a study by Leyla Yavuz Saricay, MD, and colleagues published in Ophthalmology that shows the capacity of cenegermin to improve corneal staining and visual